Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class I · High risk

Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared AMA Wholesale D-0821-2018
Class II · Moderate risk

NEOstigmine Methylsulfate

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Terminated Sterility / contamination Premier Pharmacy Labs Inc NDC 69623-234-14 D-0702-2018
Class II · Moderate risk

Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile…

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Terminated Sterility / contamination Premier Pharmacy Labs Inc NDC 69623-249-10 D-0701-2018
Class II · Moderate risk

Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile…

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Terminated Sterility / contamination Premier Pharmacy Labs Inc NDC 69623-127-10 D-0700-2018
Class II · Moderate risk

Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile…

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Terminated Sterility / contamination Premier Pharmacy Labs Inc NDC 69623-129-10 D-0699-2018

Recalls by year